PBT up 58% on margin lift, but receivable days stretched to 79

Reported EBITDA of $31.5m was up 4.3%, and Materials Handling gross margin lifted from 22% to 26% while Protein and Mining held in the high-20s to high-30s.

NPAT grew 82.3% to $14.4m, but that figure is flattered by a fall in the effective tax rate from 29.6% to 18.3%; PBT growth of 58.2% is the cleaner operating read.

Operating cash flow stepped up to $22.3m from $6.0m, and capex more than halved to $4.1m, leaving net debt down to $12.3m and leverage at 0.4x EBITDA. Against that, trade debtors rose 48.3% to $59.6m and receivable days extended from 53.2 to 79.

• With revenue flat, the 58.2% lift in PBT and the 4ppt gross-margin lift in Materials Handling indicate that the stated focus on "higher-margin contracts" is showing up in segment economics. This matters because Scott's earnings growth from here is more dependent on contract selectivity than on top-line acceleration.

• The receivables build is a project-industrials red flag. Trade debtors absorbed $19.4m of working capital and operating working capital rose $18.1m, taking debtor days up by roughly 26. For a project-based business, that pattern is consistent with later-stage billings, slower customer sign-off, or larger end-of-year deliveries — any of which raise execution risk on cash realisation.

• The tax line and lower capex flatter the optics. The effective tax rate fell roughly 11ppt and capex dropped 60.2% to 1.5% of revenue. Both helped NPAT (+82.3%) and FCF/NPAT (126.3%) look stronger than the underlying PBT trajectory; investors should anchor on PBT and operating margin rather than on the headline NPAT or conversion ratios.

The release frames FY25 as second-half weighted: HY25 carried 44.2% of revenue, 38.6% of EBITDA and only 30.3% of NPAT, so the FY25 result leans heavily on H2 execution that may or may not annualise.

Against the stated Destination 2030 target of $530m revenue by FY30, the required revenue CAGR is around 14%, which is materially above what FY25 delivered. The release does not provide FY26 numerical guidance, so this briefing focuses on what the result does and does not support: it supports the margin-lift narrative, but it does not yet evidence the top-line acceleration the 2030 target implies.

The PBT step-up of 58.2% on flat revenue is durable to the extent the margin mix holds, and the Materials Handling and Protein margin moves suggest some structural improvement rather than pure timing. The dividend framing is consistent with this: the full-year dividend is 8.0cps in both FY25 and FY24, with the company-disclosed payout ratio falling to 46% of NPAT (from 82.5%), so the higher final component reflects rebalancing within an unchanged annual dividend rather than a policy step-up.

The cash quality is weaker than the headline implies. Operating cash flow of $22.3m and FCF pre-lease of $18.2m benefited from a 60.2% drop in capex and from a prior-year comparable that was depressed by working-capital anomalies. With OWC up $18.1m and debtor days at 79, the cash result is partly balance-sheet-assisted, and FCF/NPAT of 126.3% is unlikely to be a steady-state level.

This briefing cannot assess customer-specific receivable ageing, the timing of post-year-end cash collection on the $59.6m debtor book, or the durability of the FY25 segment-margin mix without segment commentary on contract pipeline composition.